dihydroxyphenylalanine has been researched along with Insulin Resistance in 2 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alekseeva, GG | 1 |
| Zaripova, ZKh | 1 |
| Velikanova, LI | 1 |
| Savushkina, AS | 1 |
| Iukhlova, NA | 2 |
2 other studies available for dihydroxyphenylalanine and Insulin Resistance
| Article | Year |
|---|---|
[Role of insulin and its antagonists in the pathogenesis of diabetes mellitus and its complications].
Topics: Adolescent; Adult; Aged; Blood Glucose; Catecholamines; Diabetes Complications; Diabetes Mellitus; D | 1980 |
[State of the sympathetic-adrenal system in labile and resistant forms of diabetes mellitus].
Topics: Adolescent; Adrenal Glands; Adult; Aged; Blood Glucose; Catecholamines; Circadian Rhythm; Diabetes M | 1978 |